Photo by sxy_selia from unsplash
An antibody-modified nanoparticle encapsulating a pH-sensitive taxane prodrug, and targeting an overexpressed receptor in tumours, improves the tolerability and anticancer efficacy of the active drug in multiple animal models. Click to show full abstract
An antibody-modified nanoparticle encapsulating a pH-sensitive taxane prodrug, and targeting an overexpressed receptor in tumours, improves the tolerability and anticancer efficacy of the active drug in multiple animal models.
Keywords:
potent targeted;
cancer nanotherapeutic;
targeted cancer
Journal Title: Nature Biomedical Engineering
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Biomedical Engineering
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!